A Treatment for NYHA Class II-III Obstructive HCM Patients
Strategies for CV Risk Reduction in Complex T2D Patients
ASCVD Risk Reduction in Patients With T2D
Joshua Stolker, MD
PeerKeys to Helping Overcome the Growing Prevalence of Peripheral Artery Disease